Scientists develop first drug-like compounds to inhibit elusive cancer-linked enzymes
A team of scientists from the University of Michigan Rogel Cancer Center has developed the first drug-like compounds to inhibit a key family of enzymes whose malfunction is associated with several types of cancer, including ...